Treatment of neuroendocrine gut and pancreatic tumors with interferons.
Oberg
K
K
Ludwig Institute for Cancer Research Uppsala Branch, Department of Medicine, Akademiska Hospital.
D007516:Adenoma, Islet Cell / Q000628:therapy*; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002276:Carcinoid Tumor / Q000628:therapy*; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use*; D007414:Intestinal Neoplasms / Q000628:therapy*; D010190:Pancreatic Neoplasms / Q000628:therapy*; D011994:Recombinant Proteins
D000970:Antineoplastic Agents; D007370:Interferon Type I; D011994:Recombinant Proteins